Sikander Ailawadhi Md вђ Diverse Health Hub Sikander ailawadhi, md. associate professor in the division of hematology oncology, department of medicine. mayo clinic. “ we really think that access to the right healthcare is a problem. in this case, what i feel is that patients — we know these disparities exist — patients have to be their own advocates and at least ask for an opinion. In this program: is the cost of care in treating multiple myeloma higher for certain populations? in this diverse health hub interview, dr. sikander ailawadhi of mayo clinic, discusses disparities around access to care in multiple myeloma from the 61st american society of hematology (ash) meeting in orlando, florida.
Sikander Ailawadhi Md вђ Diverse Health Hub Dr. sikander ailawadhi: treatment adherence is a known phenomenon or a known issue in any of the diseases or healthcare problems whenever the treatment is given chronically. so we can imagine that if a patient had to be given treatment for 6 months, it's easy to make sure that they stay on the treatment, they take it and they get the benefit. Mayo clinic has been named one of the top most cancer centers in the country for many, many years. mayo clinic is also consistently rated the top hospital in the united states. we specialize in and offer all the available car t cell therapies and we also have several clinical trials and car t cell treatment available. Watch as dr. sikander ailawadhi from the mayo clinic explains the impact of low trial participation rates by african americans and his experience with watch as dr. sikander ailawadhi from diverse health hub. Mayo clinic. jan 2014 present 10 years 5 months. jacksonville, florida, united states.
Mayo Clinic Cancer Expert Highlights Advancements In Treating Multiple Watch as dr. sikander ailawadhi from the mayo clinic explains the impact of low trial participation rates by african americans and his experience with watch as dr. sikander ailawadhi from diverse health hub. Mayo clinic. jan 2014 present 10 years 5 months. jacksonville, florida, united states. Ailawadhi s, romanus d, shah s, fraeman k, saragoussi d, buus rm, nguyen b, cherepanov d, lamerato l, berger a. development and validation of algorithms for identifying lines of therapy in multiple myeloma using real world data. future oncol. 2024 may; 20 (15):981 995 epub 2024 jan 17. Sikander ailawadhi, m.d. professor with the division of hematology oncology, mayo clinic . dr. ailawadhi is a professor with the division of hematology oncology at mayo clinic in jacksonville and joined the division in 2014 when he moved from the universi ty of southern california, los angeles where he was an academic faculty with hematology.
Comments are closed.